Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study

about

Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study

Item

http://www.wikidata.org/entity/Q57298454

description

scientific article published on 01 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Improved diabetes medication c ...... he observational OPTIN-D study

@en

Improved diabetes medication c ...... he observational OPTIN-D study

@nl

type

Item

label

Improved diabetes medication c ...... he observational OPTIN-D study

@en

Improved diabetes medication c ...... he observational OPTIN-D study

@nl

prefLabel

Improved diabetes medication c ...... he observational OPTIN-D study

@en

Improved diabetes medication c ...... he observational OPTIN-D study

@nl

P1476

Improved diabetes medication c ...... he observational OPTIN-D study

@en

P2093

Frank J Snoek

http://www.w3.org/2001/XMLSchema#string

Jos Wr Twisk

http://www.w3.org/2001/XMLSchema#string

Maartje de Wit

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

Fear of hypoglycemia: quantification, validation, and utilization.

Missing data in a multi-item instrument were best handled by multiple imputation at the item score level.

The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.

Insulin preparations with prolonged effect.

Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.

A comprehensive review of the placebo effect: recent advances and current thought.

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

P304

e000548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJDRC-2018-000548

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas H Wieringa

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30305908

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

Insulin

P932

6169664

http://www.w3.org/2001/XMLSchema#string